Human urine contains compounds that can be chemically isolated and studied. One of the primary components is urea, a nitrogen-rich molecule with practical uses. By carefully processing and purifying ...

Nektar Therapeutics (NKTR) added ~24% in the premarket on Tuesday after the company announced that, following positive mid-stage trial data, it is launching a pivotal late-stage program for ...

NEW YORK, Feb 6 (Reuters) - An artificial intelligence-driven shakeout in the heavyweight technology sector is set to keep stock investors on edge in the coming week while a barrage of data could ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...

After Disney’s (DIS) quarterly earnings release, the share price grew to $117.50 before sinking toward $100. Disney’s quarterly revenue increased 5% year over year, but the company’s operating income ...

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Monday's key moments. 1. The S & P 500 was higher to start the new month ...

The UK government’s Department for Science, Innovation and Technology (DSIT) has completed what it calls the “discovery phase” of its bid to create a National Data Library (NDL). The NDL was trumpeted ...

The U.S. Federal Trade Commission has finalized an order with General Motors (GM) and its subsidiary, OnStar, settling charges that they collected and sold the location and driving data of millions of ...

Automatic Data Processing received authorization from its board to buy back $6 billion worth of stock. The new share repurchase authorization replaces in its entirety ADP's 2022 authorization for $5 ...

Micron is a leading maker of computer memory products that are vital to the efficient operation of AI data center servers. Its revenue, net income, and free cash flow are growing at incredible rates ...

Hightower's Stephanie Link is buying shares of SLB because she believes the world's largest oilfield services company is a hidden artificial intelligence beneficiary and the stock is cheap. "SLB is ...

A pair of phase 3 psoriasis studies of Alumis’ TYK2 inhibitor have hit their primary endpoints, setting the biotech up to file for approval of a potential challenger to Bristol Myers Squibb’s Sotyktu.